Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Loss of expression of human spectrin src homology domain binding protein 1 is associated with 10p loss in human prostatic adenocarcinoma.

Macoska JA, Xu J, Ziemnicka D, Schwab TS, Rubin MA, Kotula L.

Neoplasia. 2001 Mar-Apr;3(2):99-104.

2.
3.

Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer.

Trybus TM, Burgess AC, Wojno KJ, Glover TW, Macoska JA.

Cancer Res. 1996 May 15;56(10):2263-7.

4.

Human spectrin Src homology 3 domain binding protein 1 regulates macropinocytosis in NIH 3T3 cells.

Xu J, Ziemnicka D, Merz GS, Kotula L.

J Cell Sci. 2000 Nov;113 Pt 21:3805-14.

5.

Chromosome 10 alterations in prostate adenocarcinoma (review).

Ittmann MM.

Oncol Rep. 1998 Nov-Dec;5(6):1329-35. Review.

PMID:
9769364
6.

Allelic loss on chromosome 10 in prostate adenocarcinoma.

Ittmann M.

Cancer Res. 1996 May 1;56(9):2143-7.

7.

Functional evidence for the presence of tumor suppressor gene on chromosome 10p15 in human prostate cancers.

Fukuhara H, Maruyama T, Nomura S, Oshimura M, Kitamura T, Sekiya T, Murakami Y.

Oncogene. 2001 Jan 18;20(3):314-9.

8.

The MXI1 tumor suppressor gene is not mutated in primary prostate cancer.

Kuczyk MA, Serth J, Bokemeyer C, Schwede J, Herrmann R, Machtens S, Grünewald V, Höfner K, Jonas U.

Oncol Rep. 1998 Jan-Feb;5(1):213-6.

PMID:
9458379
9.

Abi1/Hssh3bp1 pY213 links Abl kinase signaling to p85 regulatory subunit of PI-3 kinase in regulation of macropinocytosis in LNCaP cells.

Dubielecka PM, Machida K, Xiong X, Hossain S, Ogiue-Ikeda M, Carrera AC, Mayer BJ, Kotula L.

FEBS Lett. 2010 Aug 4;584(15):3279-86. doi: 10.1016/j.febslet.2010.06.029. Epub 2010 Jun 23.

10.

Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer.

Komiya A, Suzuki H, Ueda T, Yatani R, Emi M, Ito H, Shimazaki J.

Genes Chromosomes Cancer. 1996 Dec;17(4):245-53.

PMID:
8946206
11.

Allelic loss of chromosomes 16q and 10q in human prostate cancer.

Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB.

Proc Natl Acad Sci U S A. 1990 Nov;87(22):8751-5.

12.

Salpalpha and Salpbeta, growth-arresting homologs of Sam68.

Lee J, Burr JG.

Gene. 1999 Nov 15;240(1):133-47.

PMID:
10564820
13.

Loss of the tumor suppressor PML in human cancers of multiple histologic origins.

Gurrieri C, Capodieci P, Bernardi R, Scaglioni PP, Nafa K, Rush LJ, Verbel DA, Cordon-Cardo C, Pandolfi PP.

J Natl Cancer Inst. 2004 Feb 18;96(4):269-79.

14.

Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines.

Hermans KG, van Alewijk DC, Veltman JA, van Weerden W, van Kessel AG, Trapman J.

Genes Chromosomes Cancer. 2004 Mar;39(3):171-84.

PMID:
14732919
15.

Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas.

Wang SI, Parsons R, Ittmann M.

Clin Cancer Res. 1998 Mar;4(3):811-5.

16.

Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22.

MacGrogan D, Levy A, Bova GS, Isaacs WB, Bookstein R.

Genomics. 1996 Jul 1;35(1):55-65.

PMID:
8661104
17.

MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.

Teng DH, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL, Ellis L, El-Naggar A, Frazier M, Jasser S, Langford LA, Lee J, Mills GB, Pershouse MA, Pollack RE, Tornos C, Troncoso P, Yung WK, Fujii G, Berson A, Steck PA, et al.

Cancer Res. 1997 Dec 1;57(23):5221-5.

18.
20.
Items per page

Supplemental Content

Write to the Help Desk